Gene · 23135
Papers3,078
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,078
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| KDM6B inhibition enhances chemotherapeutic response in small cell lung cancer via epigenetic regulation of apoptosis and ferroptosis. | Cell Biosci | 2025 | 41299594 | PubTator, text mining | PubMed |
| VGLL1 contributes to both the transcriptome and epigenome of the developing trophoblast compartment. | Proc Natl Acad Sci U S A | 2025 | 41284866 | PubTator, text mining | PubMed |
| Dietary Serine Restriction Impacts H3K27 and H3K4 Methyl Epigenomes to Impede Head and Neck Cancer Cell Plasticity and Tumor Growth. | bioRxiv | 2025 | 41279982 | PubTator, text mining | PubMed |
| VGLL1 contributes to both the transcriptome and epigenome of the developing trophoblast compartment. | bioRxiv | 2025 | 41278643 | PubTator, text mining | PubMed |
| Lysine demethylases 6 A and 6B as epigenetic regulators in therapeutic resistance of cancer. | Clin Epigenetics | 2025 | 41272745 | PubTator, text mining | PubMed |
| A novel risk model incorporating 4 mitochondrial unfolded protein response-related genes to predict the prognosis, gene mutation landscape, and immunotherapy response in lung adenocarcinoma. | Eur J Med Res | 2025 | 41267103 | PubTator, text mining | PubMed |
| Author Correction: JMJD3-mediated senescence is required to overcome stress-induced hematopoietic defects. | EMBO Rep | 2025 | 41225062 | PubTator, text mining | PubMed |
| Hemizygous mutation of Jmjd3 in muscle stem cells increases H3K27 methylation on Pax7 leading to impaired myogenesis. | Am J Physiol Cell Physiol | 2025 | 41212538 | PubTator, text mining | PubMed |
| Epigenetic regulation of MMP-11 and -16 expression in human prostate cancer: the role of KDM6A. | Epigenomics | 2025 | 41212163 | PubTator, text mining | PubMed |
| Exploring the potential of stem cells from the apical papilla (SCAPs) in regenerative medicine: advantages, applications, challenges and opportunities. | Stem Cell Res Ther | 2025 | 41204348 | PubTator, text mining | PubMed |
| JMJD3 upregulates ALOX5 to drive malignancy and concomitant ferroptosis sensitivity in gastric cancer. | Cell Death Dis | 2025 | 41184226 | PubTator, text mining | PubMed |
| Cancer suppresses mitochondrial chaperone activity in macrophages to drive immune evasion. | Nat Immunol | 2025 | 41162642 | PubTator, text mining | PubMed |
| JC Virus Agnogene Regulates Histone-Modifying Enzymes via PML-NBs: Transcriptomics in VLP-Expressing Cells. | Viruses | 2025 | 41157668 | PubTator, text mining | PubMed |
| The clinical and molecular spectrum of the KDM6B-related neurodevelopmental disorder. | Am J Hum Genet | 2025 | 41110445 | PubTator, text mining | PubMed |
| KDM6 Demethylases Contribute to EWSR1::FLI1-Driven Oncogenic Reprogramming in Ewing Sarcoma. | Cancer Res | 2025 | 41085408 | PubTator, text mining | PubMed |
| Functional diversity of disorder-specific macrophages involved in various diseases. | Inflamm Regen | 2025 | 41035106 | PubTator, text mining | PubMed |
| Machine learning reveals ferroptosis and therapeutic targets in rheumatoid arthritis. | Medicine (Baltimore) | 2025 | 41029156 | PubTator, text mining | PubMed |
| KDM6B promotes ferroptosis in rheumatoid arthritis fibroblast-like synoviocytes via the miR-128-3p/SLC7A11 axis through H3K27me3 modification. | J Orthop Surg Res | 2025 | 41024237 | PubTator, text mining | PubMed |
| Variable efficiency of nonsense-mediated mRNA decay across human tissues, tumors and individuals. | Genome Biol | 2025 | 41023738 | PubTator, text mining | PubMed |
| Multi-omics analysis of parthanatos related molecular subgroup and prognostic model development in stomach adenocarcinoma. | PLoS One | 2025 | 41004487 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23135/papers?page=6